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Adoption of robotic 
surgery: driven by 
market competition or a 
desire to improve 
patient care?
Authors’ reply
In our paper,1 we describe how 
competitive forces have strongly 
influenced the configuration of 
prostate cancer services, leading to the 
closure of one in four of the centres 
providing prostate cancer surgery in 
the National Health Service (NHS) in 
England.
From our analysis, patients were 
more likely to travel to hospitals that 
provided robotic surgery, frequently 
bypassing their local service if this 
technology was not available. Sean 
Fletcher and colleagues indicate that 
they disagree with our assertion 
that the rapid adoption of robotic 
surgery took place in the absence 
of evidence that it produced better 
outcomes. They point out that an 
observational study, published in 
2012,2 reported shorter hospital stay, 
fewer perioperative complications, 
and a lower blood transfusion rate 
in patients who had a robot-assisted 
prostatectomy than in those who had 
open surgery.
However, we feel that it is unlikely 
this publication had an impact on 
the adoption of robotic surgery in 
the NHS in England during our study 
period (2010–014), because there 
is a considerable lag time between 
the decision to purchase robotic 
equipment and the ability to provide 
robotic surgery. Additionally, the rapid 
integration of robotic surgery was 
already continuing apace at the time 
these data were published. Finally, 
there was—and still is—a dearth of 
robust evidence on the effectiveness 
of robotic surgery on long-term 
functional outcomes and cancer 
cure.3,4 
We do not view competition in 
a negative light. However, we do 
feel that its effect on the ability of 
health services to provide equitable, 
affordable, high-quality care should be 
carefully scrutinised. 
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